Carbylan Therapeutics, Inc. — Form D

Carbylan Therapeutics, Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-03-05. The offering totals $4.0M, of which $4.0M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Steven L BastaDirectorMenlo Park, CA
Albert L ChaDirectorMenlo Park, CA
DAVID W CLAPPERDirectorPALO ALTO, CA
Keith A KatkinDirectorSan Diego, CA
Guy P NohraDirectorSan Francisco, CA
DAVID M RENZIDirectorPALO ALTO, CA
EDWARD W UNKARTDirectorPALO ALTO, CA
REZA P ZADNODirectorPALO ALTO, CA
DAVID M GRAVETTExecutive OfficerPALO ALTO, CA
HAYLEY M LEWISExecutive OfficerPALO ALTO, CA
MARCEE M MARONEYExecutive OfficerPALO ALTO, CA
DAVID M RENZIExecutive OfficerPALO ALTO, CA
T. MICHAEL WHITEExecutive OfficerPALO ALTO, CA
Chris EhrlichDirectorSouth San Francisco, CA
STEVEN BASTADirectorBRIDGEWATER, NJ
Mark WeeksExecutive OfficerMENLO PARK, CA
Albert ChaDirectorPALO ALTO, CA
Guy NohraDirectorSan Clemente, CA
TIMOTHY L TRAPPExecutive OfficerPALO ALTO, CA
Marcee MaroneyExecutive OfficerPalo Alto, CA
Roxanne DuboisExecutive OfficerPalo Alto, CA
David GravettExecutive OfficerPalo Alto, CA
George DaniloffDirectorPalo Alto, CA
George DaniloffExecutive OfficerPalo Alto, CA

Other filings by this issuer (2)

FiledFormOfferingSold
2014-10-14D$5.0M$5.0M
2013-01-03D$13.2M$6.0M

More